CONTINUING MEDICAL EDUCATION (CME) QUESTIONS|
        March 16, 2023
    del(1p32), a powerful prognostic factor in myeloma Free
                    
                        CME
                    
        
Blood (2023) 141 (11): 1367.
        Connected Content
                            
                        A related article has been published: 
                                                                Biallelic deletion of 1p32 defines ultra-high-risk myeloma, but monoallelic del(1p32) remains a strong prognostic factor
                
            
        Citation
  del(1p32), a powerful prognostic factor in myeloma. Blood 2023; 141 (11): 1367. doi: https://doi.org/10.1182/blood.2023019948
Download citation file:
 
